Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Nexalin Technology Inc.

NXL
Current price
3.34 USD -0.48 USD (-12.57%)
Last closed 3.8 USD
ISIN unknown
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 40 229 080 USD
Yield for 12 month +882.35 %
1Y
3Y
5Y
10Y
15Y
NXL
21.11.2021 - 28.11.2021

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas. Address: 1776 Yorktown, Houston, TX, United States, 77056

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3 USD

P/E ratio

Dividend Yield

Current Year

+110 748 USD

Last Year

+1 321 357 USD

Current Quarter

+36 031 USD

Last Quarter

+26 840 USD

Current Year

-1 302 856 USD

Last Year

+958 145 USD

Current Quarter

+23 337 USD

Last Quarter

-287 887 USD

Key Figures NXL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -6 401 655 USD
Operating Margin TTM -4832.42 %
PE Ratio
Return On Assets TTM -118.92 %
PEG Ratio
Return On Equity TTM -202.23 %
Wall Street Target Price 3 USD
Revenue TTM 150 159 USD
Book Value 0.43 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -24.5 %
Dividend Yield
Gross Profit TTM 958 145 USD
Earnings per share -0.72 USD
Diluted Eps TTM -0.72 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics NXL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History NXL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation NXL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 248.3032
Price Sales TTM 267.9099
Enterprise Value EBITDA 0.0236
Price Book MRQ 29.7767

Financials NXL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NXL

For 52 weeks

0.25 USD 4.05 USD
50 Day MA 1.29 USD
Shares Short Prior Month 71 143
200 Day MA 1.13 USD
Short Ratio 0.56
Shares Short 93 398
Short Percent 1.03 %